MedTrace Logo

Patient Preference for Biopsy Notification

NCT02213471 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 301

Last updated 2014-08-11

No results posted yet for this study

Summary

Effective communication between physician and patient is fundamental to effective care. The recent introduction of electronic patient on-line portals has the potential to change the communication landscape. The investigators surveyed patients to assess their preferred modality for biopsy notification at 3 institutions with differing patient access to on-line portals, to ascertain what patient preferences are currently and if it has changed from historical preferences. Our hypothesis is that as patients become more familiar with ln-line portals, their preferences will likely reflect familiarity with this modality.

Conditions

  • Elevated Risk for Melanoma

Sponsors & Collaborators

  • Maria Wei

    lead OTHER

Principal Investigators

  • Maria L Wei, MD PhD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02213471 on ClinicalTrials.gov